Pyridine

Pyridine

SCHEMBL6069596

C#Cn1ncc2ccc(N(COCC[Si](C)(C)C)c3ccccc3C(=O)O)cc21.c1ccncc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL5206533 0.73 DGAT1 (0.31)
SCHEMBL6069602 0.68 KDR (0.33)
Pyridine SCHEMBL5241809 0.61 NOTUM (0.32)
SCHEMBL31378467 0.59 PTPN11 (0.40)
SCHEMBL32687927 0.57 DHODH (0.36)
SCHEMBL23193772 0.57 BRD4 (0.39)
SCHEMBL29974789 0.57 BRD4 (0.39)
SCHEMBL31480241 0.56 NPC1 (0.40)
SCHEMBL8577459 0.55 ALDH1A1 (0.58)
SCHEMBL21988831 0.54 HSD17B10 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053107-B2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use AGOURON PHARMACEUTICALS, INC. (US) 2006-05-30 US disclosed
US-20040192735-A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use AGOURON PHARMACEUTICALS, INC. 2004-09-30 US disclosed